BioPharm Systems Joins Oracle Accelerate Program
BioPharm Systemsannounced that ASCEND has been approved as an Oracle Accelerate Solution. ASCEND is a pre-configured and enhanced version of Oracle's Siebel Clinical Trial Management System, a CRM-based solution for the centralized management of global clinical trials, designed to make this system affordable for organizations of all sizes. BioPharm Systems’ clinical trial management system (CTMS) accelerator reduces implementation costs and timeframes, and includes robust capabilities. The system can be implemented on-premises or hosted and managed by BioPharm Systems.
ASCEND has been on the market for less than two years and has been implemented at numerous global biopharmaceutical and clinical research organizations. In addition, ASCEND is also available on a software-as-a-service (SaaS) platform.
Putting Collective Insights Into Action to Advance Cancer Care: Key Examples From ASCO 2025
June 27th 2025At ASCO 2025, clinical operations leaders gained critical insights into how AI tools, bispecific antibodies, and evolving treatment paradigms are reshaping trial design, endpoint selection, and patient stratification.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
Funding Cuts Threaten Diversity in Clinical Research
June 27th 2025In this video interview, Kyle McAllister, co-founder, CEO, Trially, discusses how recent federal funding cuts are likely to undermine research focused on underrepresented populations, and why long-term investment in community-based studies is essential to closing persistent health equity gaps.
